Adicet Bio Inc. - ACET Company Short-Term Debt

Graphic logo of Adicet Bio (ACET)

Adicet Bio is developing innovative T-cell therapies to combat lymphoma. Changes in short-term liabilities confirm current financial dynamics, where 0.00 reflects the latest metric value. Strategic collaboration with scientific centers is expanding the trial base, while partnership payments for joint projects support operational activities until the final stages of proprietary drug development are launched.

ACET (adicetbio.com) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

Adicet Bio Inc. - analytical breakdowns and key metrics (ACET)

- price and consensus price forecast:
Price Chart Adicet|ACET - Fair Value Consensus
- market capitalization data:
Market Value Adicet Bio, Inc.|ACET - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Adicet Bio|ACET - Book Capitalization|Market Cap to Net Assets Ratio adicetbio.com|ACET - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Adicet Bio|ACET - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Adicet|ACET - Company Total Debt|Debt to Book Capitalization Ratio Adicet Bio, Inc.|ACET - Company Long-Term Liabilities|Company Current Liabilities Adicet Bio
Fundamental company valuation:adicetbio.com - ACET
Product sample of Adicet

Adicet Bio (ACET) maintains complex cryogenic logistics to deliver viable cell therapies to cancer patients, which requires significant operating expenses. By analyzing the short-term borrowing ratio, an investor assesses obligations maturing within one year to determine the balance between financial flexibility and default risk, allowing this chart to reveal the business's ability to withstand macroeconomic shocks.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts ADPT|Celldex Corp - Short-Term Debt Volume|AUPH: Company Short-Term Debt|BCRX: Company Current Liabilities|VERA (Vera Therapeutics) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|PHVS (Pharvaris Corp) - Company Current Liabilities|Company Short-Term Debts ABCL|Company Short-Term Debt Tourmaline Bio, Inc. TRML|Company Short-Term Indebtedness precigen.com (PGEN)|PHAR: Company Short-Term Debts|Short-Term Debt Nektar Therapeutics Inc NKTR|Upstream Bio Corp - Company Short-Term Debts|ZBIO - Company Short-Term Debts|Company Short-Term Debts Immunome, Inc.|gossamerbio.com (GOSS) - Company Short-Term Indebtedness|KALV: Company Short-Term Debts|Short-Term Debt Volume Septerna, Inc.|Company Short-Term Debts PVLA (Pieris Pharmaceuticals Inc)|Company Current Liabilities Savara Pharma (SVRA)|RIGL: Company Short-Term Debts|ANAB - Short-Term Debt|Company Current Liabilities Astria Therapeutics, Inc. ATXS|enGene Holdings Inc (ENGN) - Amount of Current Liabilities|Company Current Liabilities RAPT Therapeutics RAPT|Aerovate Therapeutics (JBIO) - Company Short-Term Loans and Borrowings|Company Short-Term Debts Aclaris Therapeutics|Company Short-Term Debt kyvernatx.com|TLSA (Tiziana Life Sciences Ltd) - Company Short-Term Debts|Short-Term Debt Volume CABA (Cabaletta Bio Inc.)|VTYX: Company Short-Term Debt|Short-Term Debt Theratechnologies, Inc THTX|Avalo Therapeutics, Inc - Company Short-Term Debts|ELDN - Company Short-Term Debts|AGEN (Agenus Inc.) - Company Short-Term Debts|Climb Bio Inc. (CLYM) - Company Current Liabilities|Company Short-Term Debts ZURA (Zura Bio)|Short-Term Debt aTyr Pharmaceuticals (ATYR)|Company Current Liabilities Adagene|Amount of Current Liabilities IMA (ikenaoncology.com)|Shattuck Labs (STTK) - Company Short-Term Debt|Current Liabilities Equillium Inc EQ|Company Short-Term Debts Connect Pharma (CNTB)|IMUX - Company Short-Term Loans and Borrowings|ATRA: Company Short-Term Debts|IFRX (InflaRx) - Company Short-Term Debts|XFOR - Company Short-Term Debt|Company Short-Term Loans and Borrowings CELU|Company Short-Term Debt INMB (INmune Bio Corp)|Company Current Liabilities Barinthus Biotherapeutics Corp (BRNS)|Company Short-Term Debts KZR (Kezar Life Sciences)|SABS - Company Short-Term Debts|Company Current Liabilities Akari Therapeutics Plc (AKTX)|ENLV - Company Short-Term Loans and Borrowings|q32bio.com - Company Short-Term Debts|GOVX (GeoVax Corp) - Short-Term Debt Volume|Company Short-Term Debt EDSA|Company Current Liabilities IBIO|Company Short-Term Debt CARM (Carisma Therapeutics)|Company Current Liabilities XTL Biopharmaceuticals Ltd XTLB|Company Current Liabilities BOLT (Bolt Biotherapeutics, Inc.)|HCW Biologics, Inc. - Company Short-Term Debts|Aptevo (APVO) - Company Short-Term Debt|AIM - Company Short-Term Indebtedness|Company Short-Term Debts ADTX|GRI Bio Inc (GRI) - Short-Term Debt|XRTX (XORTX) - Company Short-Term Debts|Company Short-Term Debts Vyome Therapeutics|Company Short-Term Debts Revelation Biosciences REVB|Company Short-Term Indebtedness indaptusrx.com (INDP)|Company Short-Term Debts SCNI|Short-Term Debt Volume CalciMedica Inc CALI|AFMD: Company Short-Term Debts|ALLK - Company Current Liabilities|Company Short-Term Debts HOOK|Short-Term Debt IGM Biosciences|iTeos Therapeutics, Inc. (ITOS) - Company Current Liabilities|Amount of Current Liabilities Ocean Biomedical Inc (OCEA)|TC BioPharm (Holdings) PLC (TCBP) - Company Current Liabilities|Company Short-Term Loans and Borrowings Third Harmonic Bio Inc (THRD)